Browse All
Displaying 1 - 3 of 3
Author:Müller-Miny, Louisa Haessner, Svea Straeten, Frederike Schulte-Mecklenbeck, Andreas Wiendl, Heinz Grauer, Oliver Meyer zu Hörste, Gerd
Session Name:S38: Autoimmune Neurology: Peripheral Autoimmunity, Paraneoplastic Disease, Checkpoint Inhibitors, and Neurosarcoidosis
Topic:Autoimmune Neurology
Program Number:S38.006
Author Institution:University Hospital Münster, Münster, Germany University of Muenster, Muenster, Germany
Author:Bar-Or, Amit Wiendl, Heinz De Seze, Jerome Correale, Jorge Cross, Anne Derfuss, Tobias Selmaj, Krzysztof Winthrop, Kevin Giacomini, Paul Sacca, Francesco Hu, Xixi Sullivan, Roseanne Jehl, Valentine Boer, Ibolya Bhatt, Alit Hauser, Stephen
Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2
Topic:Multiple Sclerosis
Program Number:P9.007
Author Institution:Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA University of Muenster, Muenster, Germany University Hospital of Strasbourg, Strasbourg, France Institute for Neurological Research Dr. Raul Carrea, Buenos Aires, Argentina Washington University School of Medicine, Clayton, MO Neurology Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine and Biomedicine, University Hospital and University of Basel, Basel, Switzerland Center for Neurology, Lodz, Lodz, Poland Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada NSRO Department, University “Federico II” of Naples, Naples, Italy Novartis Pharmaceuticals Corporation, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland Novartis Healthcare Pvt. Ltd., Hyderabad, India UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA
Author:Bermel, Robert Carr, Warner Chitnis, Tanuja Dörner, Thomas Hayama, Koremasa Hide, Michihiro Maurer, Marcus Montalban, Xavier Sussman, Gordon Wiendl, Heinz Dahale, Swapnil DeLasHeras, Virginia Haemmerle, Sibylle Kieseier, Bernd Lheritier, Karine Zharkov, Artem Willi, Roman Giménez-Arnau, Ana
Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3
Program Number:P10.018
Author Institution:Cleveland Clinic, Cleveland, OH Allergy and Asthma Associates of Southern California, and Southern California Research, Mission Viejo, CA Brigham and Women's Hospital, Boston, MA Charite Universitätsmedizin Berlin, Berlin, Germany Nihon University School of Medicine, Tokyo, Japan Hiroshima Citizens Hospital, Minami-ku, Japan Charité - Universitätsmedizin Berlin, Berlin, Germany Vall Hebron University Hospital-Multiple Sclerosis Centre of Catalonia, Barcelona, Spain Gordon Sussman Clinical Research Inc., North York, ON, Canada University of Muenster, Muenster, Germany IQVIA, Mumbai, India Novartis Pharma AG, Basel, Switzerland Novartis, Basel, Switzerland Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain
